Abdelghani Omari
Director of Finance/CFO chez PROTEOME SCIENCES PLC
Profil
Abdelghani Omari is currently the Chief Financial Officer & Director at Proteome Sciences Plc, a Director at TheraSci Ltd., Co-Managing Director at Paion Deutschland GmbH, and Managing Director & Director at Paion Holdings UK Ltd.
He is also a former Non-Executive Director at PAION, Inc. and former Chief Financial Officer at PAION AG.
He received his undergraduate degree from RWTH Aachen University.
Postes actifs de Abdelghani Omari
| Sociétés | Poste | Début |
|---|---|---|
| PROTEOME SCIENCES PLC | Director of Finance/CFO | 01/09/2022 |
Paion Holdings UK Ltd.
 Paion Holdings UK Ltd. Financial ConglomeratesFinance Part of PAION AG, Paion Holdings UK Ltd. functions as an investment holding private company. The company is based in Edinburgh, UK. The British company was founded in 1996. Abdelghani Omari has been the CEO of the company since 2012. | Chief Executive Officer | 07/02/2012 |
Paion Deutschland GmbH
 Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Chief Executive Officer | - |
Paion UK Ltd.
 Paion UK Ltd. Pharmaceuticals: MajorHealth Technology Part of PAION AG, Paion UK Ltd. is a specialty pharmaceutical company that develops and commercializes innovative drugs for out-patient and hospital-based sedation and critical care services. Paion was founded in 1995 and is based in Cambridge, UK, with another site in Germany. Paion's vision is to become an acknowledged "PAIONeer" in sedation and critical care services. The British company's lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic drug candidate. The private company is mainly focusing on completing the development program for procedural sedation and planning to continue the clinical development program for remimazolam in the indication general in the EU. | Director/Board Member | 07/02/2012 |
TheraSci Ltd.
 TheraSci Ltd. Pharmaceuticals: MajorHealth Technology TheraSci Ltd. provides health supplements for doctors, healthcare practitioners, and medical professionals. The private company is based in Cambridge, UK and was founded by Ann Gail Hayes. The British company's products include supplements for cardiometabolic, gastrointestinal, immune health, pain, hormone support, stress, sleep support, general wellness, and body composition. TheraSci aims to provide a high-quality nutraceutical sales and service platform that streamlines the product purchase and delivery process, while minimizing impact on physician workflow and optimizing patient health outcomes. | Director/Board Member | - |
Anciens postes connus de Abdelghani Omari
| Sociétés | Poste | Fin |
|---|---|---|
| PAION AG | Director of Finance/CFO | 01/06/2022 |
PAION, Inc.
 PAION, Inc. Pharmaceuticals: MajorHealth Technology Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The private company is based in Mahwah, NJ. | Director/Board Member | - |
Formation de Abdelghani Omari
| RWTH Aachen University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PAION AG | Health Technology |
| PROTEOME SCIENCES PLC | Health Technology |
| Entreprise privées | 5 |
|---|---|
TheraSci Ltd.
TheraSci Ltd. Pharmaceuticals: MajorHealth Technology TheraSci Ltd. provides health supplements for doctors, healthcare practitioners, and medical professionals. The private company is based in Cambridge, UK and was founded by Ann Gail Hayes. The British company's products include supplements for cardiometabolic, gastrointestinal, immune health, pain, hormone support, stress, sleep support, general wellness, and body composition. TheraSci aims to provide a high-quality nutraceutical sales and service platform that streamlines the product purchase and delivery process, while minimizing impact on physician workflow and optimizing patient health outcomes. | Health Technology |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The private company is based in Mahwah, NJ. | Health Technology |
Paion Holdings UK Ltd.
Paion Holdings UK Ltd. Financial ConglomeratesFinance Part of PAION AG, Paion Holdings UK Ltd. functions as an investment holding private company. The company is based in Edinburgh, UK. The British company was founded in 1996. Abdelghani Omari has been the CEO of the company since 2012. | Finance |
Paion UK Ltd.
Paion UK Ltd. Pharmaceuticals: MajorHealth Technology Part of PAION AG, Paion UK Ltd. is a specialty pharmaceutical company that develops and commercializes innovative drugs for out-patient and hospital-based sedation and critical care services. Paion was founded in 1995 and is based in Cambridge, UK, with another site in Germany. Paion's vision is to become an acknowledged "PAIONeer" in sedation and critical care services. The British company's lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic drug candidate. The private company is mainly focusing on completing the development program for procedural sedation and planning to continue the clinical development program for remimazolam in the indication general in the EU. | Health Technology |
